Skip to main content
. 2022 Sep 12;207(3):300–311. doi: 10.1164/rccm.202201-0217OC

Table 5.

Post-transplant Mortality by Diagnosis and Era

  Before the 2015 LAS Revision
After the 2015 LAS Revision
Overall Group B (PAH) Group A (COPD) Group C (CF) Group D (ILD) Overall Group B (PAH) Group A (COPD) Group C (CF) Group D (ILD)
Died at 30 d 579 (4) 40 (8) 126 (3) 38 (2) 375 (4) 357 (2) 36 (5) 77 (2) 17 (1) 227 (2)
Alive at 30 d 14,740 (96) 479 (92) 4,386 (97) 1,891 (98) 7,984 (96) 14,802 (98) 712 (95) 3,497 (98) 1,231 (99) 9,362 (98)
Died at 1 yr 2,254 (15) 87 (17) 563 (12) 204 (11) 1,400 (17) 1,378 (11) 84 (14) 281 (9) 102 (9) 911 (12)
Alive at 1 yr 13,065 (85) 432 (83) 3,949 (88) 1,725 (89) 6,959 (83) 11,402 (89) 528 (87) 2,813 (91) 1,095 (91) 6,966 (88)
Died at 3 yr 4,730 (31) 175 (34) 1,262 (28) 528 (27) 2,765 (33) 1,914 (25) 85 (26) 454 (24) 179 (21) 1,196 (26)
Alive at 3 yr 10,589 (69) 344 (66) 3,250 (72) 1,401 (73) 5,594 (67) 5,653 (75) 242 (74) 1,432 (76) 658 (79) 3,321 (74)

For definition of abbreviations, see Table 1.

Data presented as number (%) of patients alive and number of patients dead at 30 days after transplant, 1 year after transplant, and 3 years after transplant. Registrants stratified by LAS category. LAS category A represents registrants with COPD. LAS category B represents registrants with PAH. LAS category C represents registrants with CF. LAS category D represents registrants with ILD.